Cite Filings / DNLI / 0001950047-24-002811

Feed Companies Filings Check

Sign in

144

Sale of Securities

Denali Therapeutics Inc. Filed 2024-04-01 Acc 0001950047-24-002811

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2024-04-15 144 Sale of Securities
2024-04-02 4 Director sold 92,500 shares at $20.50 ($1,896,250)
2024-04-01 144 Sale of Securities
2024-03-29 4 President and CEO gave 40,000 shares (gift)
2024-02-14 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…